Fertility medications like Clomid and Letrozole are best suited for people with ovulation issues, such as people with polycystic ovary syndrome (PCOS) or people with unexplained infertility.

You may not be a candidate if you have one or more of the following:

• Blocked fallopian tubes

• Low ovarian reserve or age-related fertility decline

• Fibroids or ovarian cysts.

• Inflamed veins or liver disease.

• Depression.

• BMI

• A history of liver problems

• Women whose history of infertility is unrelated to ovulation

No, medications are not included in the membership fee. Your medications will typically be sent to your local pharmacy and should cost $50 - $100 per month or less.

The initial consultation is $65, due at the time of checkout. After that, membership for the program is $198 per month. This includes follow-up appointments, 1:1 wellness coaching, and tools and insights around nutrition, environmental toxins, and exercise that can improve your outcome.

The monthly subscription fee doesn’t start until after you complete the initial consultation.

Additionally, we’re running a promotion to receive $99 off your first month for people that sign up to the waitlist now.

We try to make the program as risk-free as possible, so if you’re unhappy for any reason, then you can unsubscribe at any time.

We don’t take insurance for the membership cost yet, but we will work with your commercial or employer insurance to get your labs and medication covered.

A literature review published in Human Reproduction on the fertility drug Clomid found success rates for just over 5,000 women and found that:

• 73% eventually ovulated on Clomid

• 29% gave birth

The actual success rate of different fertility medications depend on the cause of the issue.

This program is specifically focused on people who struggle with heavy menstrual bleeding due to uterine fibroids.

Upon sign-up, you will fill out a form to see if you are qualified to receive fibroid medications, coaching, or both.

If your clinical care provider prescribes ORIAHNN, the following results are shown for premenopausal women aged 25-53 with heavy periods due to uterine fibroids.

After 6 months of taking ORIAHNN, average bleeding was reduced by about 81% (189 mL) compared with an average decrease of about 3% (9 mL) in women taking placebo.

ORIAHNN was proven to lighten heavy periods in about 7 out of 10 women.

If your ELANZA clinician prescribes you ORIAHNN, it is clinically proven to reduce heavy menstrual bleeding due to uterine fibroids in as soon as 1 month. In the ORIAHNN clinical trials, most women had their bleeding volume reduced by at least 50% from the start of trial to Month 1.

No, medications are not included in the membership fee. You may qualify for insurance coverage, coupons, or financial assistance based on your circumstances.

Your medications will typically be sent to your local pharmacy for pickup.

The initial consultation is $65, due at the time of checkout. After that, membership for the program is $198 per month. This includes follow-up appointments, 1:1 wellness coaching, and tools and insights around nutrition, environmental toxins, and exercise that can improve your symptoms.

The monthly subscription fee doesn’t start until after you complete the initial consultation.

Additionally, we’re running a promotion for $99 off your first month for people that sign up for the waitlist.

We try to make the program as risk-free as possible, so if you’re unhappy for any reason, then you can unsubscribe at any time.

We don’t take insurance for the membership cost yet, but we will work with your commercial or employer insurance to get your labs and medication covered.

Even if your ELANZA clinician prescribes you ORIAHNN, it was not specifically studied in women with anemia. Before starting ORIAHNN, 100 women in the 2 ORIAHNN clinical trials had low levels of hemoglobin, which can be a sign of anemia. After taking ORIAHNN for 6 months, many of these women (about 5 in 10) saw an increase in their hemoglobin levels compared with nearly 2 in 10 women taking placebo. It is important to note that most of these women (90%) also took an iron supplement.